SavedAdd your journal

Journals / Turkish Journal of Clinics and Laboratory / 2017 / Cilt: 8 - Sayı: 3

The relationship between acute exacerbation of chronic obstructive pulmonary disease and neutrophile-to-lymphocyte ratio, serum uric acid and gamma-glutamyl transferase levels

Kronik obstrüktif akciğer hastalığının akut alevlenmesi ile nötrofil-lenfosit oranı ve serum ürik asit düzeyleri arasındaki ilişki

Nalan OGAN
Sezen BAĞLAN UZUNGET
Berkay EKİCİ
Pages
105–112
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With regard to the associations between chronic obstructive pulmonary disease and these parameters, they can be used to determine disease burden besides other risk factors in routine clinical practice.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Chronic inflammation plays a pathogenic role in chronic obstructive pulmonary disease.
📊
Key Findings & Data:Increase in the ratio of circulating neutrophil to lymphocyte ratio (NLR), serum uric acid and gamma-glutamyl transferase (GGT) levels may serve as a marker of systemic inflammation.
💡
Conclusion & Impact:With regard to the associations between chronic obstructive pulmonary disease and these parameters, they can be used to determine disease burden besides other risk factors in routine clinical practice.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:kronik obstriktif akciğer hastalığı · nötrofil lenfosit oranı inflamasyon · C reaktif protein

Abstract

Aim: Chronic inflammation plays a pathogenic role in chronic obstructive pulmonary disease. Increase in the ratio of circulating neutrophil to lymphocyte ratio (NLR), serum uric acid and gamma-glutamyl transferase (GGT) levels may serve as a marker of systemic inflammation. The aim of this study is to evaluate the potential predictive value of blood neutrophil-to- lymphocyte NLR and possible role of serum uric acid and gamma-glutamyl transferase levels as biomarkers in chronic obstructive pulmonary disease patients.Material and Methods: The sample was derived from a population of 276 patients admitted for acute exacerbation of chronic obstructive pulmonary disease to our respiratory medicine department.Results: Higher N/L ratios, uric acid and GGT levels were detected in chronic obstructive pulmonary disease patients than in the controls (P < 0.001). Positive correlations between smoking (pack-years) and NLR, serum GGT, uric acid, and C- reactive protein levels were found (P < 0.001; r = 0.339, P < 0.001; r = 0.224, P < 0.001;r = 0.242,and P < 0.001; r = 0.563, respectively). Conclusion: Our study demonstrated that NLR, serum GGT and uric acid levels are significantly higher in patients with chronic obstructive pulmonary disease. With regard to the associations between chronic obstructive pulmonary disease and these parameters, they can be used to determine disease burden besides other risk factors in routine clinical practice.

Özet

Amaç: Kronik inflamasyon, kronik obstrüktif akciğer hastalığında (KOAH) patojenik bir rol oynamaktadır. Dolaşımdaki nötrofil-lenfosit oranı (N / L oranı), serum ürik asit ve gama-glutamil transferaz (GGT) düzeylerindeki artış, sistemik bir iltihabın göstergesi olabilir. Bu çalışmanın amaı KOAH'lı hastalarda biyolojik belirteç olarak kan nötrofil-lenfosit (N / L) oranı ile serum ürik asit ve gama-glutamil transferaz (GGT) düzeylerinin muhtemel rolü üzerindeki olası değerini değerlendirmektir. Gereç ve Yöntemler: Retrospektif bir çalışma.Gereç ve Yöntem: Örneklem, KOAH'ın stabil ve akut alevlenmesi için göğüs hastalıkları bölümümüze başvuran 260 hastadan (stabil KOAH, n = 68, KOAH'ın akut alevlenişi, n = 192) oluşturuldu. Bulgular: KOAH hastalarının akut alevlenmesinde yüksek N / L oranları ve serum ürik asit seviyeleri tespit edildi (p &lt;0.01). Sigara (paket-yıllar) ile N / L oranı ve C-reaktif protein düzeyleri arasında pozitif korelasyon bulundu (sırasıyla p = 0.014; r = 0.153 ve p = 0.001; r = 0.252). Sonuçlar: Çalışmamız, akut KOAH alevlenmesi olan hastalarda N / L oranı ve serum ürik asit düzeylerinin belirgin olarak daha yüksek olduğunu göstermiştir. Kronik obstrüktif akciğer hastalığı ile bu parametreler arasındaki ilişkilerle ilgili olarak, rutin klinik uygulamada diğer risk faktörlerinin yanında hastalık yükünü belirlemek için kullanılabilirler.

🔖

Cite This Article

OGAN, N., UZUNGET, S. B., EKİCİ, B. (2017). The relationship between acute exacerbation of chronic obstructive pulmonary disease and neutrophile-to-lymphocyte ratio, serum uric acid and gamma-glutamyl transferase levels. Turkish Journal of Clinics and Laboratory, Cilt: 8 - Sayı: 3, 105–112. https://ajindex.com/articles/372979

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Rodriguez-Roisin R: Toward a consensus definition for COPD exacerbations. Chest 2000; 117: 398S-401S
  2. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007; 29: 1224-1238
  3. Dentener MA, Creutzberg EC, Schols AM, et al. Systemic anti-inflammatory mediators in COPD: increase in soluble inteleukin 1 receptor II during treatment of exacerbations. Thorax 2001; 56: 721-726
  4. Agusti A, Sin DD. Biomarkers in COPD. Clin Chest Med 2014; 35:131-41
  5. Casaburi R, celli B, Crapo J, et al. The COPD Biomarker Qualification Consortium (CBQC). COPD 2013; 10:367-77
  6. Bartziokas K, Papaioannou A.I, Loukides S, et al. Papadopoulos A, Haniotou A, Papiris S, Kostikas K. Serum uric asid as a predictor of mortality and future exacerbations of COPD. Eur Respir J 2014; 43:43-53
  7. Ermis H, Celik M.R, Gulbas G, Tavli D, Aytemur Z.A. Relationship between serum γ-glutamyltransferase levels and acute exacerbation of chronic obstructive pulmonary disease. Pol Arch Med Wewn 2013; 123: 85-90
  8. The Global Initiative for Chronic Obstructive Lung Diseas (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2014
  9. Jones PW, Harding G, Berry P, et al.Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648-54
  10. Bathoorn E, Liesker JJ, Postma DS, et al. Change in inflammation in out-patient COPD patients from stable phase to a subsequent excerbation. Int J Chron Obstruct Pulmon Dis 2009; 4:101-109
  11. Stolz D, Christ-Crain M, Morgenthaler NG, et al. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest 2007; 131:1058-1067
  12. Dahl M, Vestbo J, Lange P, et al. C-reactive protein as a predictor of pronosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:250-255
  13. Hurst JR, Vestbo J, Anzueto A, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363:1128-1138
  14. Lebowitz MD, Postma DS. Adverse effects of smoking on the natural history of newly diagnosed chronic bronchitis. Chest 1995; 108: 55–61
  15. Segal AW. How neutrophils kill microbes. Annu Rev Immunol 2005; 23: 197-223
  16. Chan-Yeung M, Dybuncio A. Leucocyte count, smoking and lung function. Am J Med 1984; 76: 31–37